IAVI  //

Scripps Research

Devin Sok,
Programme Director, SRPNTS

By building partnerships across global health for antibody discovery and development, we have the potential to make significant public health impact at all levels, from global pandemics like HIV to neglected tropical diseases like snakebite envenomation

 
  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
Neutralizing Antibody Center, La Jolla
A non-profit scientific research organization. Their mission is to translate scientific discoveries into affordable, globally accessible public health solutions.
  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
Scripps Research, La Jolla
Scripps Research advances scientific understanding, educates the scientists of tomorrow, and impacts human health across the globe. They are science changing life.

Leads.

 

DENNIS
BURTON

Scientific Director, NAC

Dennis Burton is a Principle Investigator of the SRPNTS consortium and is the Chair of the Department of Immunology and Microbiology at Scripps Research, Scientific Director at the NAC, and Director of the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID). His group is focused on developing rational vaccine strategies, particularly against HIV and particularly using an approach termed “Reverse Vaccinology 2.0”. In this approach, broadly neutralizing antibodies isolated from natural HIV infection are investigated in interaction with their sole viral target, the HIV Envelope, and the data used to guide immunogen design and immunization strategies. Dennis received his bachelor’s degree from the University of Oxford and his PhD from Lund University in Sweden.

OLAYINKA FAGBAYI 

Program Director, NAC

Olayinka Fagbayi is a member of the SRPNTS programmatic operations team and is the Programme Director at IAVI’s Neutralizing Antibody Center based at The Scripps Research Institute in La Jolla, CA. Olayinka works with internal and external stakeholders to oversee and ensure the coordination, administration, and implementation of SRPNTS programme as well as all other NAC programmes mainly focusing on HIV but also encompasses other disease areas. To define and execute on the high-impact scientific activities, Olayinka serves as a resource and interface for SRPNTS leadership, staff, partners, and donors for the effective design and delivery of the scientific and programmatic vision. She earned her bachelor’s degree in Biology, with a research focus in glycobiology, from Stanford University.

HESTER
KUIPERS  

Europe Director, IAVI

Hester Kuipers is a member of the SRPNTS programmatic operations team and is IAVI’s Executive Director, Europe. She directly liaises with the Department for International Development (DFID), our SRPNTS donor, and its program officers in managing our productive relationship. She leads her team and office from its base in Amsterdam and oversees the Resource Mobilization, Advocacy and Communications programs, as well as IAVI’s relations in Europe with donors, government representatives, researchers, civil society, and the press. Hester joined IAVI Europe in 2006, initially as Director Communications and from 2010 as Director Advocacy & Communications. Hester has a Master’s of Science degree in Biology from the University of Utrecht in The Netherlands.

DEVIN
SOK

Senior Director, NAC

Devin Sok is the Programme Director as well as technical co-Director of the SRPNTS consortium and is the Senior Director of Antibody Discovery and Development for IAVI. His group is currently focused on antibody discovery against variable pathogens or targets (e.g. HIV, snakebite, AMR), understanding antibody-mediated protection, characterization of antibody responses to candidate immunogens, and product development of lead antibodies for therapy and prophylaxis. Devin is generally interested in the mechanisms of antibody-mediated protection against infectious diseases and antibody product development to prevent or treat neglected diseases that affect low- and middle-income countries. Devin received his bachelor’s degree from Stanford University and his PhD from The Scripps Research Institute.

JOSEPH
JARDINE

Director, NAC

Recombinant toxin & synthetic antibody library development

Team members.

 

LAETITIA MISSON MINDREBO

Post-doctoral scientist, NAC

SVMP: toxin development & antibody discovery

MEGAN
VERMA

Research Associate, NAC

Research support to SVMP and PLA2 projects

IRENE

KHALEK

Post-doctoral scientist, NAC

Recombinant toxin & synthetic antibody library development

KAREN SAYE-FRANCISCO

Research Associate, Scripps

Recombinant toxin purification

SHAUN
PALMER

Communications Associate, IAVI

Website design

macro-1208503-1400x933.jpg

OLIVER
LIMBO

Senior Research Associate, NAC

-

macro-1208503-1400x933.jpg

JORDAN
WOEHL

Protein Scientist, NAC

-